Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
2008 · New England Journal of Medicine · 964 citations
https://doi.org/10.1056/nejmoa0805002
M
Michael A. Weber
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
825
Papers
45.1K
Citations
93
h-index
389
i10-index
Michael A. Weber is an academic researcher from State University of New York. The author has contributed to research in topics: Blood Pressure and Hypertension Studies & Hormonal Regulation and Hypertension & Heart Rate Variability and Autonomic Control. The author has an h-index of 93, co-authored 702 publications.
ORCID: 0000-0002-8504-0831Papers by this author
worksEndovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
2018 · The Lancet · 689 citations
https://doi.org/10.1016/s0140-6736(18)31082-1
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
2020 · The Lancet · 555 citations
https://doi.org/10.1016/s0140-6736(20)30554-7
May Measurement Month 2017: an analysis of blood pressure screening results worldwide
2018 · The Lancet Global Health · 331 citations
https://doi.org/10.1016/s2214-109x(18)30259-6
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
2017 · The Lancet · 305 citations
https://doi.org/10.1016/s0140-6736(17)30754-7
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
2022 · The Lancet · 269 citations
https://doi.org/10.1016/s0140-6736(22)00455-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat